Old Web
English
Sign In
Acemap
>
Paper
>
BRAF Mutant NSCLC and Immune Checkpoint Inhibitors: Results From a Real-World Experience
BRAF Mutant NSCLC and Immune Checkpoint Inhibitors: Results From a Real-World Experience
2019
Karim Rihawi
Diana Giannarelli
Domenico Galetta
Angelo Delmonte
Marco Giavarra
D. Turci
Marina Chiara Garassino
Marcello Tiseo
Fausto Barbieri
Stefano Panni
Andrea Ardizzoni
Keywords:
Cancer research
Pathology
Mutant
Immune checkpoint
Medicine
Microsatellite instability
Carcinoma
immune checkpoint inhibitors
MEDLINE
B7-H1 Antigen
Correction
Source
Cite
Save
Machine Reading By IdeaReader
7
References
10
Citations
NaN
KQI
[]